Product nameAnti-Granzyme K antibody
See all Granzyme K primary antibodies
DescriptionRabbit polyclonal to Granzyme K
Tested applicationsSuitable for: ELISA, WB, IHC-P, ICC/IFmore details
Species reactivityReacts with: Human
Predicted to work with: Mouse, Rat
Synthetic peptide derived from the internal region of human Granzyme K.
- Human lung carcinoma tissue. NIH/3T3 cells. Extracts from Jurkat cells.
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferpH: 7.40
Preservative: 0.02% Sodium azide
Constituents: 0.87% Sodium chloride, 50% Glycerol, PBS
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab69884 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/500 - 1/1000. Detects a band of approximately 34 kDa (predicted molecular weight: 29 kDa).|
|IHC-P||1/50 - 1/100.|
|ICC/IF||1/500 - 1/1000.|
Tissue specificityExpressed in lung, spleen, thymus and peripheral blood leukocytes.
Sequence similaritiesBelongs to the peptidase S1 family. Granzyme subfamily.
Contains 1 peptidase S1 domain.
Cellular localizationSecreted. Cytoplasmic granule.
- Information by UniProt
- Fragmentin 3 antibody
- Fragmentin-3 antibody
- Fragmentin3 antibody
All lanes : Anti-Granzyme K antibody (ab69884) at 1/500 dilution
Lane 1 : Extracts from Jurkat cells
Lane 2 : Extracts from Jurkat cells with immunising peptide at 5 µg
Lysates/proteins at 5 µg per lane.
Predicted band size: 29 kDa
Observed band size: 34 kDa why is the actual band size different from the predicted?
Immunohistochemistry analysis of paraffin-embedded human lung carcinoma tissue using ab69884 at 1/50 dilution in the presence or absence of the immunising peptide.
Immunofluorescence analysis of NIH/3T3 cells using ab69884 at 1/500 dilution in the presence or absence of the immunising peptide.
ab69884 has not yet been referenced specifically in any publications.